One Wealth Advisors LLC Buys 168 Shares of McKesson Co. (NYSE:MCK)

One Wealth Advisors LLC boosted its stake in McKesson Co. (NYSE:MCK) by 7.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,414 shares of the company’s stock after acquiring an additional 168 shares during the quarter. One Wealth Advisors LLC’s holdings in McKesson were worth $1,376,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of McKesson by 206.7% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 460 shares of the company’s stock valued at $269,000 after purchasing an additional 310 shares during the last quarter. Centaurus Financial Inc. boosted its holdings in shares of McKesson by 23.4% in the 2nd quarter. Centaurus Financial Inc. now owns 348 shares of the company’s stock valued at $203,000 after buying an additional 66 shares during the last quarter. Czech National Bank increased its holdings in McKesson by 6.6% during the third quarter. Czech National Bank now owns 26,416 shares of the company’s stock worth $13,061,000 after buying an additional 1,645 shares during the last quarter. GAMMA Investing LLC raised its position in McKesson by 18.0% during the third quarter. GAMMA Investing LLC now owns 2,698 shares of the company’s stock worth $1,334,000 after acquiring an additional 411 shares in the last quarter. Finally, Diversified Trust Co grew its position in shares of McKesson by 2.0% in the 3rd quarter. Diversified Trust Co now owns 8,463 shares of the company’s stock valued at $4,184,000 after acquiring an additional 164 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Price Performance

Shares of MCK opened at $594.85 on Monday. The stock has a 50-day moving average of $590.79 and a 200-day moving average of $561.94. McKesson Co. has a one year low of $464.42 and a one year high of $637.51. The company has a market cap of $75.51 billion, a PE ratio of 30.81, a P/E/G ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The firm had revenue of $93.65 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same period last year, the firm earned $6.23 earnings per share. The business’s quarterly revenue was up 21.3% compared to the same quarter last year. Analysts expect that McKesson Co. will post 32.72 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be issued a $0.71 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. McKesson’s dividend payout ratio is currently 14.71%.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Robert W. Baird upgraded McKesson from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $531.00 to $688.00 in a research note on Thursday, November 7th. StockNews.com upgraded McKesson from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Leerink Partners lowered their target price on McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a research note on Monday, October 7th. Citigroup lowered their price objective on McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Finally, Bank of America reduced their target price on shares of McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $646.14.

Insider Activity at McKesson

In related news, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the sale, the executive vice president now directly owns 864 shares in the company, valued at approximately $494,890.56. This trade represents a 40.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.11% of the stock is owned by insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.